1-3 of 3
Arnt V Kristen
Close
Sort by
Journal Articles

Lenalidomide/Melphalan / Dexamethasone Chemotherapy In 50 Patients With Newly Diagnosed Amyloid Light Chain Amyloidosis: First Results Of a Prospective Single Center Phase 2 Study (Leomex)

Stefan O Schonland, MD, Tilmann Bochtler, MD, Axel Benner, Marianne Gawlik, Christoph Kimmich, Arnt V Kristen, Jörg Beimler, Anthony D. Ho, MD, Ute Hegenbart, MD
Journal: Blood
Blood (2013) 122 (21): 1993.
https://doi.org/10.1182/blood.V122.21.1993.1993
Published: 2013
Journal Articles

Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay

Clinical Trials & Observations
Arnt V. Kristen, Evangelos Giannitsis, Stephanie Lehrke, Ute Hegenbart, Matthias Konstandin, David Lindenmaier, Corina Merkle, Stefan Hardt, Philipp A. Schnabel, Christoph Röcken, Stefan O. Schonland, Anthony D. Ho, Thomas J. Dengler, Hugo A. Katus
Journal: Blood
Blood (2010) 116 (14): 2455–2461.
https://doi.org/10.1182/blood-2010-02-267708
Published: 2010
Journal Articles

Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement

Clinical Trials & Observations
Sascha Dietrich, Stefan O. Schönland, Axel Benner, Tilmann Bochtler, Arnt V. Kristen, Jörg Beimler, Ernst Hund, Markus Zorn, Hartmut Goldschmidt, Antony D. Ho, Ute Hegenbart
Journal: Blood
Blood (2010) 116 (4): 522–528.
https://doi.org/10.1182/blood-2009-11-253237
Published: 2010